Rickettsia Clearance Study

NCT05972772 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Infectious Disease
Therapeutics

Interventions

DRUG: Doxycyclin
DRUG: Azithromycin

Sponsor

Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit

Collaborators

[object Object]